.After a handful of years in biotech, Mike Quigley, Ph.D., is actually coming back to the pharma fol...
.Achilles Rehabs has actually torn up its own strategy. The British biotech is stopping work on its ...
.Aligos Therapeutics is trumpeting a midstage win in metabolic-dysfunction linked steatohepatitis (M...
.Basilea Pharmaceutica's job establishing new antifungals has received a significant increase from t...
.Having presently gathered up the USA civil liberties to Capricor Therapies' late-stage Duchenne mus...
.After pushing back the choice meeting for Applied Rehabs' metabolic disorder drug govorestat, the F...
.Novo Nordisk is continuing its press right into hereditary medications, accepting to pay NanoVation...
.Innovent Biologics has produced the instance that its own checkpoint inhibitor-cytokine fusion heal...
.A stage 3 trial of Daiichi Sankyo as well as Merck & Co.'s HER3-directed antibody-drug conjugate...
.Five months after Rakovina Rehabs turned towards artificial intelligence, the cancer-focused biotec...